Skip to content
Home/Companies/Healthcare/PulseSight Therapeutics

PulseSight Therapeutics

Healthcare·France·Exited 2019·Held 2yr
Entry
2017
Hold
2yr
Exit
2019

Who owns PulseSight Therapeutics?

PulseSight Therapeutics was owned by Karista through CapDecisif 3 (2013 vintage) from 2017 to 2019, exited via MBO.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Karista
Investor
Karista
CapDecisif 3 · 2013 · VC

Key facts

HQFrance
SectorHealthcare
Exit Type
MBO
Buyer
MOIC
–
Exit Year
2019

More from CapDecisif 3

Other portfolio companies in the same fund.

Acticor Biotech
Exited 2025
BiotechFrance· 2017
Endodiag
Endodiag
Active
BiotechFrance· 2017
PayinTech
Active
FinancialsFrance· 2017
Actvt
Active
SoftwareFrance· 2016
E(ye)Brain
E(ye)Brain
Active
HealthcareFrance· 2016
Minka Therapeutics
Exited 2022
HealthcareFrance· 2016
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track PulseSight Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PulseSight Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PulseSight Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue